Pfizer is inquiring the US federal government to allow for use of its COVID-19 vaccine in little ones aged 5 to 11.
If regulators concur, photographs could begin in a matter of months.
Pfizer currently had announced that a decreased dose of its vaccine labored and appeared secure in a study of the children.
Pfizer and its German spouse BioNTech on Thursday formally filed its application with the Food stuff and Drug Administration.
FDA’s advisers are scheduled to debate the evidence on Oct 26.
Until eventually now, the vaccine was out there only to those as younger as 12.
Little ones at present make up about 27 per cent of all US coronavirus circumstances and an escalating percentage of hospitalisations, according to the American Academy of Pediatrics.
That reflects the significant contagiousness of the Delta variant among the unvaccinated men and women.
When children are less prone to intense COVID-19, they can unfold the virus to other folks, together with vulnerable populations that are a lot more at hazard of serious sickness.